Implications of Combining, Sequencing Liver-directed Therapy With Systemic Therapy for Liver Metastases
Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, discusses the implications of research into the treatment of liver metastases in patients with gastrointestinal NETs.
Pharmacy Times interviewed Gaby Gabriel, MD, program director, interventional radiology residency and assistant program director, diagnostic radiology residency, University of Kentucky, on his presentation at the 2021 NANETS Multidisciplinary Neuroendocrine Tumors (NETs) Medical Virtual Symposium discussing sequencing and combination of liver-directed therapy with systemic therapies.
During the interview, Gabriel discussed the implications of research into the treatment of liver metastases in patients with gastrointestinal NETs.
